© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A combination of two targeted therapies led to long-lasting remission in a small study of patients with hairy cell leukemia.
Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
Imbruvica-based treatment may also work better than intensive chemotherapy for younger patients.
Filling in the unknowns on the balance between risk and benefit
Venclexta combination therapy clears leukemia in blood and bone marrow, recent studies show.
Revlimid improves outcomes for chronic lymphocytic leukemia patients, but better drugs are now available.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
